| Profile | GDS5420 / 238488_at |
| Title | Psoriasis response to brodalumab: dose response and time course |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM1296094 | A_lesional_pre-dose | 158.44 | 49 |
| GSM1296119 | B_lesional_pre-dose | 442 | 66 |
| GSM1296076 | C_lesional_pre-dose | 360.83 | 63 |
| GSM1296092 | D_lesional_pre-dose | 448.51 | 66 |
| GSM1296103 | E_lesional_pre-dose | 256.35 | 57 |
| GSM1296078 | F_lesional_pre-dose | 338.31 | 63 |
| GSM1296107 | G_lesional_pre-dose | 454.2 | 66 |
| GSM1296109 | H_lesional_pre-dose | 437.29 | 65 |
| GSM1296080 | I_lesional_pre-dose | 328.58 | 61 |
| GSM1296090 | J_lesional_pre-dose | 331.49 | 62 |
| GSM1296074 | K_lesional_pre-dose | 327.28 | 62 |
| GSM1296111 | L_lesional_pre-dose | 346.17 | 61 |
| GSM1296099 | M_lesional_pre-dose | 468.22 | 66 |
| GSM1296086 | O_lesional_pre-dose | 317.71 | 61 |
| GSM1296117 | P_lesional_pre-dose | 421.73 | 65 |
| GSM1296113 | Q_lesional_pre-dose | 243.84 | 54 |
| GSM1296096 | R_lesional_pre-dose | 395.08 | 64 |
| GSM1296105 | S_lesional_pre-dose | 821.63 | 76 |
| GSM1296098 | T_lesional_pre-dose | 229.37 | 54 |
| GSM1296101 | U_lesional_pre-dose | 354.62 | 61 |
| GSM1296121 | V_lesional_pre-dose | 476.62 | 67 |
| GSM1296088 | W_lesional_pre-dose | 579.88 | 70 |
| GSM1296082 | X_lesional_pre-dose | 196.11 | 54 |
| GSM1296115 | Y_lesional_pre-dose | 308.89 | 59 |
| GSM1296084 | Z_lesional_pre-dose | 347.61 | 62 |
| GSM1296072 | B_lesional_day8 | 566.95 | 70 |
| GSM1296069 | L_lesional_day8 | 556.26 | 69 |
| GSM1296071 | P_lesional_day8 | 731.05 | 74 |
| GSM1296070 | Y_lesional_day8 | 482.2 | 67 |
| GSM1296073 | V_lesional_day8 | 342.33 | 62 |
| GSM1296034 | A_lesional_day15 | 579 | 69 |
| GSM1296041 | G_lesional_day15 | 238.66 | 55 |
| GSM1296035 | R_lesional_day15 | 277.42 | 58 |
| GSM1296038 | U_lesional_day15 | 495.1 | 68 |
| GSM1296047 | B_lesional_day15 | 728.73 | 74 |
| GSM1296039 | E_lesional_day15 | 425.15 | 65 |
| GSM1296042 | H_lesional_day15 | 605.03 | 71 |
| GSM1296043 | L_lesional_day15 | 612.11 | 71 |
| GSM1296037 | M_lesional_day15 | 546.13 | 69 |
| GSM1296046 | P_lesional_day15 | 565.04 | 69 |
| GSM1296044 | Q_lesional_day15 | 371.8 | 62 |
| GSM1296045 | Y_lesional_day15 | 428.36 | 65 |
| GSM1296025 | C_lesional_day15 | 1237.19 | 82 |
| GSM1296033 | D_lesional_day15 | 646.71 | 72 |
| GSM1296027 | I_lesional_day15 | 558.68 | 70 |
| GSM1296032 | J_lesional_day15 | 419.92 | 64 |
| GSM1296024 | K_lesional_day15 | 890.23 | 77 |
| GSM1296031 | W_lesional_day15 | 784.11 | 75 |
| GSM1296028 | X_lesional_day15 | 422.8 | 65 |
| GSM1296029 | Z_lesional_day15 | 927.34 | 78 |
| GSM1296026 | F_lesional_day15 | 790.88 | 75 |
| GSM1296030 | O_lesional_day15 | 239.33 | 57 |
| GSM1296040 | S_lesional_day15 | 408.27 | 64 |
| GSM1296036 | T_lesional_day15 | 314.89 | 59 |
| GSM1296048 | V_lesional_day15 | 581.63 | 70 |
| GSM1296059 | A_lesional_day43 | 274.08 | 58 |
| GSM1296066 | G_lesional_day43 | 401.55 | 64 |
| GSM1296060 | R_lesional_day43 | 480.95 | 67 |
| GSM1296063 | U_lesional_day43 | 411.9 | 65 |
| GSM1296064 | E_lesional_day43 | 235.51 | 56 |
| GSM1296067 | H_lesional_day43 | 1120.23 | 81 |
| GSM1296062 | M_lesional_day43 | 524.15 | 68 |
| GSM1296068 | Q_lesional_day43 | 572.67 | 70 |
| GSM1296050 | C_lesional_day43 | 1115.27 | 81 |
| GSM1296057 | D_lesional_day43 | 1138.69 | 81 |
| GSM1296052 | I_lesional_day43 | 743.03 | 74 |
| GSM1296054 | J_lesional_day43 | 517.95 | 68 |
| GSM1296049 | K_lesional_day43 | 1015.01 | 79 |
| GSM1296055 | W_lesional_day43 | 825.15 | 76 |
| GSM1296053 | X_lesional_day43 | 737.04 | 74 |
| GSM1296058 | Z_lesional_day43 | 485.13 | 67 |
| GSM1296051 | F_lesional_day43 | 622.61 | 72 |
| GSM1296056 | O_lesional_day43 | 344.24 | 62 |
| GSM1296065 | S_lesional_day43 | 633.45 | 72 |
| GSM1296061 | T_lesional_day43 | 508.1 | 67 |
| GSM1296095 | A_non-lesional_pre-dose | 306.88 | 60 |
| GSM1296120 | B_non-lesional_pre-dose | 498.4 | 68 |
| GSM1296077 | C_non-lesional_pre-dose | 939.89 | 78 |
| GSM1296093 | D_non-lesional_pre-dose | 811.47 | 75 |
| GSM1296104 | E_non-lesional_pre-dose | 291.4 | 59 |
| GSM1296079 | F_non-lesional_pre-dose | 1078.23 | 80 |
| GSM1296108 | G_non-lesional_pre-dose | 561.34 | 70 |
| GSM1296110 | H_non-lesional_pre-dose | 728.72 | 74 |
| GSM1296081 | I_non-lesional_pre-dose | 656.61 | 72 |
| GSM1296091 | J_non-lesional_pre-dose | 287.19 | 59 |
| GSM1296075 | K_non-lesional_pre-dose | 526.65 | 69 |
| GSM1296112 | L_non-lesional_pre-dose | 615.87 | 71 |
| GSM1296100 | M_non-lesional_pre-dose | 506.21 | 67 |
| GSM1296087 | O_non-lesional_pre-dose | 426.19 | 66 |
| GSM1296118 | P_non-lesional_pre-dose | 639.96 | 72 |
| GSM1296114 | Q_non-lesional_pre-dose | 319.02 | 59 |
| GSM1296097 | R_non-lesional_pre-dose | 512.25 | 68 |
| GSM1296106 | S_non-lesional_pre-dose | 791.22 | 75 |
| GSM1296102 | U_non-lesional_pre-dose | 511.74 | 67 |
| GSM1296122 | V_non-lesional_pre-dose | 1023.55 | 80 |
| GSM1296089 | W_non-lesional_pre-dose | 628.11 | 71 |
| GSM1296083 | X_non-lesional_pre-dose | 602.71 | 70 |
| GSM1296116 | Y_non-lesional_pre-dose | 523.32 | 68 |
| GSM1296085 | Z_non-lesional_pre-dose | 420.76 | 65 |